\\ˈdeprəˌnil\ noun (-s)
Etymology: perhaps from International Scientific Vocabulary dimethyl + propyne + phenethyl
: an optically active compound C13H17N that is an inhibitor of monoamine oxidase usually administered in the form of its levorotatory hydrochloride especially in the treatment of Parkinson's disease

Useful english dictionary. 2012.

Look at other dictionaries:

  • Deprenyl — ДЕПРЕНИЛ ( Deprenyl ). L ( ) N (1 фенилизопропил) N метил N 2 пропиниламин. Синонимы: Селегилин, Юмекс, Selegiline, Eldepryl, Jumex, Tumex. По химической структуре близок к эфедрину (см.) и другим симпатомиметическим аминам, но по действию… …   Словарь медицинских препаратов

  • deprenyl — noun Etymology: perhaps from International Scientific Vocabulary dimethyl + propionic acid + phenyl + ethyl Date: 1975 a monoamine oxidase inhibitor C13H17N used especially to treat Parkinson s disease …   New Collegiate Dictionary

  • deprenyl — An inhibitor of monoamine oxidase selective for the type B isozyme. The drug is used as an antiparkinsonian agent. It does not give rise to the hypertensive crisis that can occur when nonselective monoamine oxidase inhibitors are taken in the… …   Medical dictionary

  • deprenyl — dep·re·nyl …   English syllables

  • D-Deprenyl — Systematic (IUPAC) name (2S) N methyl 1 phenyl N prop 2 ynyl propan 2 amine Clinical data Pregnancy cat …   Wikipedia

  • L-deprenyl — L de·pren·yl (depґrə nəl) selegiline …   Medical dictionary

  • Selegiline — Systematic (IUPAC) name (R …   Wikipedia

  • Methylbenzodioxolylpentanamine — IUPAC name 1 (1,3 benzodioxol 5 yl) N methylpentan 2 amine …   Wikipedia

  • Ethylbenzodioxolylpentanamine — IUPAC name 1 (1,3 benzodioxol 5 yl) N ethylpentan 2 amine …   Wikipedia

  • Methylenedioxyhydroxyamphetamine — Systematic (IUPAC) name %28%C2%B1%29 1 %28benzo[d][1%2C3]dioxol 5 yl%29 N hydroxylpropan 2 amine Clinical data Trade names …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.